T-cell receptor (TCR) binding to peptide/MHC is key to antigen-specific cellular immunity, and there has been considerable interest in modulating TCR affinity and specificity for the development of therapeutics and imaging reagents. While in vitro engineering efforts using molecular evolution have yielded remarkable improvements in TCR affinity, such approaches do not offer structural control and can adversely affect receptor specificity, particularly if the attraction towards the MHC is enhanced independently of the peptide. Here we describe an approach to computational design that begins with structural information and offers the potential for more controlled manipulation of binding properties. Our design process models point mutations in selected regions of the TCR and ranks the resulting change in binding energy. Consideration is given to designing optimized scoring functions tuned to particular TCR-peptide/MHC interfaces. Validation of highly ranked predictions can be used to refine the modeling methodology and scoring functions, improving the design process. Our approach results in a strong correlation between predicted and measured changes in binding energy, as well as good agreement between modeled and experimental structures.
T cell receptor Structure-guided design Rosetta Binding
This is a preview of subscription content, log in to check access
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
Computational structural immunology in the authors’ laboratories is supported by NIH grants R01GM103773 and R01GM067079 and an award from the Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut. TPR is supported by a fellowship from the Indiana CTSI, funded in part by NIH grant UL1TR001108.
Zhao Y, Bennett AD, Zheng Z et al (2007) High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. J Immunol 179:5845–5854CrossRefPubMedPubMedCentralGoogle Scholar
Michielin O (2007) Application of molecular modeling to new therapeutic cancer approaches. Bull Cancer 94:763–768PubMedGoogle Scholar
Haidar JN, Pierce B, Yu Y et al (2009) Structure‐based design of a T‐cell receptor leads to nearly 100‐fold improvement in binding affinity for pepMHC. Proteins 74:948–960CrossRefPubMedPubMedCentralGoogle Scholar
Borbulevych OY, Santhanagopolan SM, Hossain M et al (2011) TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms. J Immunol 187:2453–2463CrossRefPubMedPubMedCentralGoogle Scholar
Scott DR, Borbulevych OY, Piepenbrink KH et al (2011) Disparate degrees of hypervariable loop flexibility control T-cell receptor cross-reactivity, specificity, and binding mechanism. J Mol Biol 414:385–400CrossRefPubMedPubMedCentralGoogle Scholar
Burrows SR, Chen Z, Archbold JK et al (2010) Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Proc Natl Acad Sci 107:10608–10613CrossRefPubMedPubMedCentralGoogle Scholar
Borbulevych OY, Piepenbrink KH, Gloor BE et al (2009) T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. Immunity 31:885–896CrossRefPubMedPubMedCentralGoogle Scholar
Sammond DW, Eletr ZM, Purbeck C et al (2007) Structure-based protocol for identifying mutations that enhance protein–protein binding affinities. J Mol Biol 371:1392–1404CrossRefPubMedPubMedCentralGoogle Scholar
Giudicelli V, Duroux P, Ginestoux C et al (2006) IMGT/LIGM-DB, the IMGT® comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Res 34:D781–D784CrossRefPubMedPubMedCentralGoogle Scholar
Kellogg EH, Leaver‐Fay A, Baker D (2011) Role of conformational sampling in computing mutation‐induced changes in protein structure and stability. Proteins 79:830–838CrossRefPubMedPubMedCentralGoogle Scholar